Te late efects of cancer and cancer treatment: A rapid review

Journal of Community and Supportive Oncology

Volumn 12, Issue 4, 2014, Pages 137-148

  Treanor, Charlene J ^a,b   Donnelly, Michael ^b  

^a Cancer Epidemiology and Health Services Research Group   (United States)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ANXIETY; CANCER SURVIVOR; CANCER THERAPY; CARDIOVASCULAR DISEASE; COGNITIVE DEFECT; DEPRESSION; DISTRESS SYNDROME; ENDOCRINE DISEASE; GASTROINTESTINAL DISEASE; HUMAN; INFERTILITY; KIDNEY DISEASE; LIVER DISEASE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MUSCULOSKELETAL DISEASE; NEUROLOGICAL COMPLICATION; NEUROTOXICITY; ONSET AGE; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PSYCHOLOGICAL ASPECT; RESPIRATORY TRACT DISEASE; REVIEW; SEXUAL DYSFUNCTION; SIDE EFFECT; SOCIAL ASPECT; TREATMENT RESPONSE; URINARY TRACT DISEASE;

EID: 84988490221     PISSN: 23307749     EISSN: None     Source Type: Journal    
DOI: 10.12788/jcso.0035     Document Type: Review

References (60)

1. Ganz PA. Late efects of cancer and its treatment. Semin Oncol Nurs. 2001;17:241-248.
2. Department of Health, Macmillan Cancer Support, NHS Improvement. Te National Cancer Survivorship Initiative Vision. London, UK: Department of Health; 2010.
3. Aziz NM, Rowland JH. Trends and advances in cancer survivorship research: challenge and opportunity. Semin Radiat Oncol. 2003;13:248-266.
4. Ataman OU, Barrett A, Davidson S, et al; REACT working group of ESTRO. Audit of efectiveness of routine follow-up clinics after radiotherapy for cancer: A report of the REACT working group of ESTRO. Radiother Oncol. 2004;73:237-249.
5. Stein KD, Syrjala KL, Andrykowski MA. Physical and psychological long-Term and late efects of cancer. Cancer. 2008;112(11 Suppl):2577-2592.
6. Smith TJ, Snyder C. Is it time for (survivorship care) plan B? J Clin Oncol. 2011;29:4740-4742.
7. Treanor CJ, Santin O, Mills M, Donnelly M. Cancer survivors with self-reported late efects: Their health status, care needs and service utilisation. Psychooncology. 2013;22:2428-2435.
8. Grant MJ, Booth AA. A typology of reviews: An analysis of 14 review types and associated methodologies. Health Info Libr J. 2009;26:91-108.
9. Watt A, Cameron A, Sturn L, et al. Rapid reviews versus full systematic reviews: An inventory of current methods and practice in health technology assessment. Int J Technol Assess Health Care. 2008;24:133-139.
10. J. Beel, B. Gipp. Google Scholars ranking algorithm: An introductory overview, in: J. Larsen, J Leta (eds). Proceedings of the 12th International Conference on Scientometrics and Informetrics, Rio de Janeiro (Brazil), July 2009, 230-241.
11. Tichelli A, Soci G. Considerations for adult cancer survivors. Hematology Am Soc Hematol Educ Program. 2005;516-522.
12. Dow KH. A review of late efects of cancer in women. Semin Oncol Nurs. 1995;11:128-136.
13. Travis LB. Te epidemiology of second primary cancers. Cancer Epidem Biomarkers Prev. 2006;15:2020-2026.
14. Foss SD, Vassilopoulou-Selin R, Dahl AA. Long-Term physical sequelae after adult-onset cancer. J Cancer Surviv. 2008;2:3-11.
15. Brearley SG, Stamataki Z, Addington-Hall J, et al. Te physical and practical problems experienced by cancer survivors: A rapid review and synthesis of the literature. Eur J Oncol Nurs. 2011;15:204-212.
16. Arden-Close E, Pacey A, Eiser C. Health-related quality of life in survivors of lymphoma: A systematic review and methodological critique. Leuk Lymphoma. 2010;51:628-640.
17. Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M. Its not over when its over: long-Term symptoms in cancer survivors-A systematic review. Int J Psychiatry Med. 2010;40:163-181.
18. Wefel JS, Lenzi R, Teriault RL, Davis RN, Meyers CA. Te cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: Results of a prospective, randomized, longitudinal trial. Cancer. 2004;100:2292-2299.
19. Stava CJ, Jimenez C, Vassilopoulou-Sellin R. Endocrine sequelae of cancer and cancer treatments. J Cancer Surviv. 2007;1:261-274.
20. Carver JR, Shapiro CL, Ng A, et al; ASCO Cancer Survivorship Expert Panel. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late efects. J Clin Oncol. 2007;25:3991-4008.
21. Schover LR. Sexuality and fertility after cancer. Hematology Am Soc Hematol Educ Program. 2005:523-527.
22. Arden-Close E, Eiser C, Pacey A. Sexual functioning in male survivors of lymphoma: A systematic review (CME). J Sex Med. 2011;8(7):1833-1841.
23. OLeary MP, Fowler FJ, Lenderking WR, et al. A brief male sexual function inventory for urology. Urology. 1995;46:697-706.
24. Jansen L, Koch L, Brenner H, Arndt V. Quality of life in long-Term (≥ 5 years) colorectal cancer survivors-systematic review. Eur J Cancer. 2010;46:2879-2888.
25. Mols F, Vingerhoets JM, Coebergh JW, van de Poll-Franse LV. Quality of life in long-Term breast cancer survivors: A systematic review. Eur J Cancer. 2005;41:2613-2619.
26. Atkinson TM, Mendoza TR, Sit L, et al. Te Brief Pain Inventory and its "pain at its worst in the last 24 hours" item: clinical trial endpoint considerations. Pain Med. 2010;11:337-346.
27. Melzack R. Te McGill Pain Questionnaire. In: Melzack R., ed. Pain measurement and assessment. New York: Raven Press; 1983:41-47.
28. Ryan M, Stainton MC, Jaconelli C, Watts S, MacKenzie P, Mansberg T. Te experience of lower limb lymphedema for women after treatment for gynecologic cancer. Oncol Nurs Forum., 2003;30:417-423.
29. Armer J, Fu MR, Wainstock JM, Zagar E, Jacobs LK. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy. Lymphology. 2004;37:73-91.
30. Schwartz JE, Jandorf L, Krupp LB. Te measurement of fatigue; a new instrument. J Psychosom Res. 1993;37:753-762.
31. Foster C, Wright D, Hill H, Hopkinson J, Rofe L. Psychosocial implications of living 5 years or more following a cancer diagnosis: A systematic review of the research evidence. Eur J Cancer Care (Engl). 2009;18:223-247.
32. Deimling GT, Bowman KF, Sterns S, Wagner LJ, Kahana B. Cancer-related health worries and psychological distress in older adult, long-Term, cancer survivors. Psychooncol. 2006;15:306-320.
33. Boyes A, DEste C, Carey M, Lecathelinais C, Girgis A. How does the Distress Termometer compare to the Hospital Anxiety and Depression Scale for detecting possible cases of psychological morbidity in cancer survivors? Support Care Cancer. 2013;21:119-127.
34. Bogaarts MP, Den Oudsten BL, Roukema JA, Van Riel JM, Beerepoot LV, De Vries J. Development of the Psychosocial Distress Questionnaire-Breast Cancer (PDQ-BC): A breast cancer-specifc screening instrument for psychosocial problems. Support Care Cancer. 2011;19:1485-1493.
35. Tewes B, Butow P, Zachariae R, Christensen S, Simard S, Gotay C. Fear of cancer recurrence: A systematic literature review of self-report measures. Psychooncology. 2012;21:571-587.
36. Baxter NW, Goodwim PJ, McLeod RS, Dion R, Devins G, Bombardier C. Reliability and validity of the body image breast cancer questionnaire. Breast J. 2006;12:221-232.
37. Cash T. Multidimensional Body Self Relations Questionnaire: MBSRQ Users Manual. Norfolk VA:Old Dominion University;1994.
38. Nakamura Y, Lipschitz Dl, Kuhn R, Kinney AY, Donaldson GW. Investigating efcacy of two brief mind-body intervention programs for managing sleep disturbances in cancer survivors: A pilot randomized controlled trial. J Cancer Surviv. 2013;7:165-182.
39. Aaronson NK, Ahmedzai S, Bergman B, et al. Te European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365-376.
40. Tors Cl, Broeckel JA, Jacobsen PB. Sexual functioning in breast cancer survivors. Cancer Control. 2001;8:442-448.
41. Ahles TA, Saykin AJ, Furstenberg CT, et al. Quality of life of long-Term survivors of breast cancer and lymphoma treated with standard-dose chemotherapy or local therapy. J Clin Oncol. 2005;23:4399-4405.
42. Tomas SF, Glynne-Jones R, Chait I, Marks DF. Anxiety in longterm cancer survivors infuences the acceptability of planned discharge from follow-up. Psychooncology. 1997;6:190-196.
43. Trask PC. Assessment of depression in cancer patients. J Natl Cancer Inst Monogr. 2004;32:80-92.
44. American Psychological Association. Diagnostic Statistical Manual of Mental Disorders. 4th ed. Text revision. Washington DC: American Psychiatric Association;2000.
45. Foa E, Cashman L, Jaycox L, Perry K. Te validation of a self-report measure of post-Traumatic stress disorder: The post-Traumatic stress diagnostic scale. Psychol Assessment. 1997;9:445-451.
46. Tedeschi RG, Calhoun LG. Te Posttraumatic Growth Inventory: measuring the positive legacy of trauma. J Trauma Stress. 1996;9:455-471.
47. Bellizzi KM, Blank TO. Predicting posttraumatic growth in breast cancer survivors. Health Psychol. 2006;25:47-56.
48. Connerty TJ, Knott V. Promoting positive change in the face of adversity: experiences of cancer and post-Traumatic growth. Eur J Cancer Care. 2013;22:334-344.
49. Zebrack BJ, Ganz PA, Bernaards CA, Petersen L, Abraham L. Assessing the impact of cancer: development of a new instrument for long-Term survivors. Psychooncology. 2006;15:407-421.
50. Common Toxicology Criteria for Adverse Efects scale: http://evs. nci.nih.gov/ftp1/CTCAE/About.html/. Accessed June 8, 2013
51. LENT-SOMA scale: http://www.christie.nhs.uk/the-foundationtrust/treatments-And-clinical-services/clinical-oncology-scoringtreatment-efects/ctcaelent-soma-questionnaires.aspx. Accessed June 8, 2013.
52. National Cancer Survivorship Initiative-Concerns Checklist; http://www.ncsi.org.uk/wp-content/uploads/MAC13689-Identifyingconcerns-Pad-v3.pdf . Accessed June 8, 2013.
53. Ell K, Xie B, Wells A, Nedjat-Haiem F, Lee PJ, Vourlekis B. Economic stress in low-income women with cancer: efects on quality of life. Cancer. 2008;112:616-625.
54. Saylor PJ, Smith MR. Adverse efects of androgen deprivation therapy: defning the problem and promoting health in men with prostate cancer, J Natl Compr Cancer Netw. 2010;8:211-223.
55. Shapiro CL, Recht A. Side efects of adjuvant treatment of breast cancer. N Engl J Med. 2001;344:1997-2008.
56. Cramp F, Byron-David J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev 2012;11:CD006145.
57. Goedendorp MM, Gielissen MF, Verhagen CA, Bleijenberg G. Psychosocial interventions for reducing fatigue during cancer treatment in adults. Cochrane Database Syst Rev. 2009;1:CD006953.
58. Minton O, Richardson A, Sharpe M, Hotopf M, Stone V. Drug therapy for the management of cancer-related fatigue. Cochrane Database Syst Rev. 2010;7:CD006704.
59. Bennett S, Purcell A, Meredith P, Beller E, Haires T. Education interventions for the management of cancer-related fatigue in adults (Protocol). Cochrane Database Syst Rev. October 7, 2009. doi:10.1002/14651858.CD008144.
60. National Cancer Institute. Coping with cancer: supportive and palliative care. http://www.cancer.gov/cancertopics/coping/. Accessed July 29, 2013.